First CAR T Therapy for Stiff Person Syndrome Shows Success

Kyverna Therapeutics (KYTX) announces positive results from clinical trial of miv-cel CAR T-cell therapy for stiff person syndrome, potentially the first FDA-approved treatment for this rare autoimmune disease.